These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 20525834)

  • 1. Modified release prednisone in patients with rheumatoid arthritis.
    Jacobs JW; Bijlsma JW
    Ann Rheum Dis; 2010 Jul; 69(7):1257-9. PubMed ID: 20525834
    [No Abstract]   [Full Text] [Related]  

  • 2. Delayed-release prednisone - a new approach to an old therapy.
    Buttgereit F; Gibofsky A
    Expert Opin Pharmacother; 2013 Jun; 14(8):1097-106. PubMed ID: 23594208
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chronotherapy with modified-release prednisone in patients with rheumatoid arthritis.
    Alten R
    Expert Rev Clin Immunol; 2012 Feb; 8(2):123-33. PubMed ID: 22288450
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacology of glucocorticoids in rheumatoid arthritis.
    Spies CM; Bijlsma JW; Burmester GR; Buttgereit F
    Curr Opin Pharmacol; 2010 Jun; 10(3):302-7. PubMed ID: 20202903
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improvement Thresholds for Morning Stiffness Duration in Patients Receiving Delayed- Versus Immediate-Release Prednisone for Rheumatoid Arthritis.
    Buttgereit F; Kent JD; Holt RJ; Grahn AY; Rice P; Alten R; Yazici Y
    Bull Hosp Jt Dis (2013); 2015 Jul; 73(3):168-77. PubMed ID: 26535595
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cutaneous Bipolaris spicifera infection in a patient on systemic corticosteroids].
    Dubois M; Brisou P; Fournier B; Guennoc B; Carsuzaa F
    Ann Dermatol Venereol; 2008; 135(6-7):507-8. PubMed ID: 18598805
    [No Abstract]   [Full Text] [Related]  

  • 7. Morning stiffness response with delayed-release prednisone after ineffective course of immediate-release prednisone.
    Alten R; Holt R; Grahn A; Rice P; Kent J; Buttgereit F; Gibofsky A
    Scand J Rheumatol; 2015; 44(5):354-8. PubMed ID: 26114379
    [TBL] [Abstract][Full Text] [Related]  

  • 8. How should impaired morning function in rheumatoid arthritis be treated?
    Buttgereit F
    Scand J Rheumatol Suppl; 2011; 125():28-39. PubMed ID: 21529308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ask the doctor. I have rheumatoid arthritis, and my doctor wants me to take prednisone for it. Will this drug be bad for my blood pressure, which is already high?
    Shmerling RH
    Harv Heart Lett; 2010 Jul; 20(11):7. PubMed ID: 20812420
    [No Abstract]   [Full Text] [Related]  

  • 10. The intelligent use of systemic glucocorticoids in rheumatoid arthritis.
    Mercieca C; Kirwan JR
    Expert Rev Clin Immunol; 2014 Jan; 10(1):143-57. PubMed ID: 24308837
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of modified-release versus standard prednisone to reduce duration of morning stiffness of the joints in rheumatoid arthritis (CAPRA-1): a double-blind, randomised controlled trial.
    Buttgereit F; Doering G; Schaeffler A; Witte S; Sierakowski S; Gromnica-Ihle E; Jeka S; Krueger K; Szechinski J; Alten R
    Lancet; 2008 Jan; 371(9608):205-14. PubMed ID: 18207016
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A fresh look at glucocorticoids how to use an old ally more effectively.
    Buttgereit F
    Bull NYU Hosp Jt Dis; 2012; 70 Suppl 1():26-9. PubMed ID: 23259655
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old But Good: Modified-Release Prednisone in Rheumatoid Arthritis.
    Ursini F; Naty S; Bruno C; Grembiale RD
    Rev Recent Clin Trials; 2017; 12(2):124-128. PubMed ID: 28356031
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Are long-term very low doses of prednisone for patients with rheumatoid arthritis as helpful as high doses are harmful?
    Pincus T; Sokka T; Stein CM
    Ann Intern Med; 2002 Jan; 136(1):76-8. PubMed ID: 11777366
    [No Abstract]   [Full Text] [Related]  

  • 15. Perioperative steroids for secondary adrenal insufficiency.
    Blavin LR; French L
    J Fam Pract; 1997 Jun; 44(6):532-3. PubMed ID: 9191621
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of novel therapeutic glucocorticoids on circadian rhythms of hormones and cytokines in rheumatoid arthritis.
    Kirwan JR; Clarke L; Hunt LP; Perry MG; Straub RH; Jessop DS
    Ann N Y Acad Sci; 2010 Apr; 1193():127-33. PubMed ID: 20398018
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is the Availability of Delayed-Release Prednisone an Important Clinical Advance?
    Conn DL
    Arthritis Care Res (Hoboken); 2016 Mar; 68(3):412-3. PubMed ID: 26414513
    [No Abstract]   [Full Text] [Related]  

  • 18. Efficacy and safety of modified-release prednisone in patients with rheumatoid arthritis.
    Krasselt M; Baerwald C
    Drug Des Devel Ther; 2016; 10():1047-58. PubMed ID: 27022244
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Corticotherapy in rheumatoid polyarthritis].
    Rev Rhum Mal Osteoartic; 1971 Nov; 38(11):655-68. PubMed ID: 4339214
    [No Abstract]   [Full Text] [Related]  

  • 20. Symptom control with low-dose glucocorticoid therapy for rheumatoid arthritis.
    Kirwan JR; Buttgereit F
    Rheumatology (Oxford); 2012 Jun; 51 Suppl 4():iv14-20. PubMed ID: 22685271
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.